7th Circuit Panel Affirms Dismissal Of Depakote RICO Class Action By Insurers

(October 13, 2017, 1:18 PM EDT) -- CHICAGO — A Seventh Circuit U.S. Court of Appeals panel on Oct. 12 affirmed dismissal of a racketeering class action against Abbott Laboratories for its off-label promotion of the seizure drug Depakote, saying there are too many layers between the drug manufacturer’s actions and Depakote prescriptions paid for by two third-party payers to prove an injury (Sidney Hillman Health Center of Rochester, et al. v. Abbott Laboratories, et at., No. 17-1483, 7th Cir., 2017 U.S. App. LEXIS 19925)....

Attached Documents

Related Sections